Clay B. Siegall
2012
In 2012, Clay B. Siegall earned a total compensation of $5.6M as President and CEO at Seattle Genetics, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $577,500 |
|---|---|
| Option Awards | $2,337,409 |
| Salary | $696,667 |
| Stock Awards | $1,937,925 |
| Other | $7,980 |
| Total | $5,557,481 |
Siegall received $2.3M in option awards, accounting for 42% of the total pay in 2012.
Siegall also received $577.5K in non-equity incentive plan, $696.7K in salary, $1.9M in stock awards and $8K in other compensation.
Rankings
In 2012, Clay B. Siegall's compensation ranked 1,057th out of 11,487 executives tracked by ExecPay. In other words, Siegall earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,057 out of 11,487 | 91st |
Division Manufacturing | 382 out of 4,252 | 91st |
Major group Chemicals And Allied Products | 89 out of 1,200 | 93rd |
Industry group Drugs | 50 out of 922 | 95th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 165 | 97th |
Source: SEC filing on April 6, 2015.
Siegall's colleagues
We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2012.
2012
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2012
Thomas Reynolds
Seattle Genetics
Chief Medical Officer
2012
Christopher Boerner
Seattle Genetics
Former EVP, Commercial
2012
Todd Simpson
Seattle Genetics
Chief Financial Officer
2012
Jonathan Drachman
Seattle Genetics